Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAP | Q12884 | 5/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.31 |
| ▸ | FURIN | P09958 | 2/20 | 0.30 |
| ▸ | NPY1R | P25929 | 1/20 | 0.30 |
| ▸ | NPY2R | P49146 | 1/20 | 0.30 |
| ▸ | NPY4R | P50391 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | GLP1R | P43220 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24864380 | 0.98 | FAP (0.40) | FAPSIRT2SIRT1FURINGLP1R | |
| SCHEMBL24864405 | 0.98 | FAP (0.40) | FAPSIRT2SIRT1FURINNPY1R | |
| SCHEMBL29340481 | 0.97 | FAP (0.40) | FAPSIRT2SIRT1FURINNPY1R | |
| SCHEMBL24864498 | 0.97 | FAP (0.40) | FAPSIRT2SIRT1GLP1R | |
| SCHEMBL29346082 | 0.95 | FAP (0.40) | FAPSIRT2SIRT1FURINGLP1R | |
| SCHEMBL24864625 | 0.94 | FAP (0.38) | FAPSIRT2SIRT1GLP1R | |
| SCHEMBL24864408 | 0.94 | FAP (0.40) | FAPFURINGLP1R | |
| SCHEMBL29346068 | 0.93 | FAP (0.41) | FAPSIRT2SIRT1FURINNPY1R | |
| SCHEMBL24864416 | 0.93 | FAP (0.40) | FAPGLP1R | |
| SCHEMBL29346067 | 0.93 | FAP (0.42) | FAPFURINNPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023280227-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2023-01-12 | — | — | WO | disclosed |